Counterfeit Irminix® is being sold under our various trade names (OSR, NBMI, Emerimide) and tests have shown that it is not Irminix®.

Counterfeit Emeramide illegally being sold to the public

We are aware some companies are selling counterfeit Emeramide. a substance that is promoted to work as our mercury chelation compound. In one case, a physician in Sweden purchased fake Emeramide online and tested it. He informed us that the product he bought online did not display the properties of our compound. Please reference the above picture. Emeramide dissolves in DMSO (clear solution) and the fake Emeramide internet counterfeit does not (as it contains an unknown white debris.)

Companies are selling counterfeit Emeramide with the warning “NOT FOR HUMAN CONSUMPTION” in big bold letters. This is good advice.

Our drug, Emeramide is pharmaceutically pure with virtually no contamination, made in the United States. It has specific physical properties and precise chemical bonds that studies have shown make it harmless to you.

What is the fake Emeramide made of?

So what is it the fake Emeramide, counterfeit drug made of? While we do not know specifically, we do know it is not the real thing. Since the counterfeit product would not dissolve in DMSO it may be a compound that has no resemblance at all chemically to Emeramide. On the other hand if at one time it was similar in structure to Emeramide it is possible the undissolved white substance is a combination of the heavy metals that Emeramide combines with irreversibly. Counterfeit Emeramide in your system may do real harm as ingestion of an unknown substance is a risk to your health.

Emeramide is a unique chelator

Emeramide is fat soluble when not combined with any of the following metals:

  • Mercury
  • Arsenic
  • Lead
  • Uranium
  • Gadolinium
  • Uranium
  • Thorium
  • Polonium

Don’t risk your health with fake chelators

Why risk your health ingesting unknown, fake, knock offs? The real Emeramide may be available in your country in compliance with various regulations through our Early Access Programme.